Most CMC (Chemistry, Manufacturing & Control) delays are predictable, yet they keep happening, because strategy and execution operate in silos.
This panel brings together leaders from biotech, pharma, and CDMOs to discuss how organizations build CMC readiness, align technical and business decisions, and close execution gaps that consume time and value. Perspectives across the development value chain, from early-stage decisions to commercial scale.
Tuesday, May 5, 14:00 - 14:45, room Shanghai 1+2
| Name | Position | Institution |
|---|---|---|
| Sonja Merkas | Founder and CEO | Livinovea GmbH |
Livinovea is a Basel-based strategic execution partner across the development and manufacturing value chain. We align scientific decisions with business strategy, and operational execution for biotech, pharma, CDMOs and startups.
Our approach: Outside perspective. Inside execution. Measurable results.
With expertise in oligonucleotides, RNA, peptide, and small-molecule modalities and conjugates, we connect science and technology with strategic goals, and translate them into operational reality.
